Yoshie Sakamaki Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Researcher

University of Arkansas at Fayetteville

faculty

8 h-index 20 pubs 230 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Yoshie Sakamaki's research focuses on developing novel therapeutic agents, particularly for cancer treatment. Her work includes the creation of bioconjugated chlorin-based metal–organic frameworks designed for targeted photodynamic therapy, specifically investigating their efficacy against triple-negative breast and pancreatic cancers. Sakamaki also investigates luminescent heterobimetallic Pt<sup>II</sup>–Au<sup>I</sup> complexes containing N-heterocyclic carbenes (NHCs) as potential anticancer agents. Her publication record includes several crystal structure determinations, indicating a focus on the structural characterization of synthesized compounds. Sakamaki collaborates with researchers at the University of Arkansas at Fayetteville, including M. Hassan Beyzavi, Yuchun Du, Zachary McConnell, and Christopher Salmon. She has authored 20 publications with 230 citations and an h-index of 8.

Metrics

  • h-index: 8
  • Publications: 20
  • Citations: 230

Selected Publications

  • Luminescent Heterobimetallic Pt<sup>II</sup>–Au<sup>I</sup> Complexes Bearing <i>N</i>-Heterocyclic Carbenes (NHCs) as Potent Anticancer Agents (2023) DOI
  • A Bioconjugated Chlorin-Based Metal–Organic Framework for Targeted Photodynamic Therapy of Triple Negative Breast and Pancreatic Cancers (2021) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics